CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Other events
- 424B5 Offering Prospectus
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Agreement ended · Acquisition or sale completed · New debt or obligation · Unregistered share sale
- 4 Open-market sale Director sold 10,000 shares at $3.05 ($30,526)
- 8-K Event Material agreement
- 8-K Event Material agreement · Other events
- EFFECT Other Notice of Effectiveness
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 24 of 44 · 872 filings